Jean‐Edouard Ombetta

Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment

Miezan J. M. Ezoulin, Chang‐Zhi Dong, Zhou Liu et al. · Toxicology in Vitro · 2006 · 34 citations

Life Sciences, Biochemistry, Pharmacology +12

Inhibition of secretory phospholipase A2. 2-Synthesis and structure–activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme

Chang‐Zhi Dong, Azali Ahamada‐Himidi, Stéphanie Plocki et al. · Bioorganic & Medicinal Chemistry · 2005 · 25 citations

Life Sciences, Biochemistry, Pharmacology +10

Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells

Miezan J. M. Ezoulin, Juan Li, Guirong Wu et al. · Neuroscience Letters · 2005 · 20 citations

Life Sciences, Biochemistry, Pharmacology +14

Inhibition of secretory phospholipase A. 1-Design, synthesis and structure–activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLAs

Leon Assogba, Azali Ahamada‐Himidi, Nadia Meddad-Bel Habich et al. · European Journal of Medicinal Chemistry · 2005 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine

Miezan J. M. Ezoulin, Zhou Liu, H. Dutertre-Catella et al. · International Immunopharmacology · 2007 · 14 citations

Medicine, Immunology, Pharmacology +13